The programming & infrastructure built for you
As part of Emory School of Medicine’s commitment to advancing biomedical innovation and entrepreneurship, Lab2Launch provides flexible and low-cost co-working and wet laboratory space to local start-up companies developing promising technologies for the benefit of human health.
Lab2Launch provides capital-efficient access to a well-rounded laboratory infrastructure, removing barriers for innovative scientist-entrepreneurs to launch and grow new ventures and generate the proof-of-concept they need to expand their technology and team.
Lab2Launch residents will also be able to leverage the network, and rich business development and technical programming provided by Biolocity - a sister program, that funds and assists promising early-stage teams through consultation and project management in their commercialization journey.
The benefits of joining the Lab2Launch Community
Available spaces:
- Lab benches in a Biosafety level 2 lab
- Private lab suites
- Desks and private office space
Lab equipment:
- General lab equipment: incubators, biosafety cabinets, centrifuges, microscopes, cell counters
- Sample analysis: multifunctional plate reader, gel and blot imager, qPCR
- Formulation: water purification system, balance, pH meter
- Glassware prep: autoclave, glass washer
- Cold storage: LN2, -80C, -20C, +4C
Lab2Launch is strategically located in the vicinity of various core facilities and resources within Emory, including a biorepository, microscopy and cellular imaging core, genomics core, and flow cytometry core.
Application timeline:
Applications are on a rolling basis. If accepted after evaluation, company onboarding and move-in can take up to two (2) months.
Application documents:
- Current business plan
- Financial statements including balance sheet, income statement and capitalization table
- Names and short bios of members of board of directors (or board of advisors)
Residency contingencies:
- Faculty associated with applicant companies must complete all Emory University intellectual property and conflict of interest disclosures and approvals.
- Company will enter into a Space Use License Agreement with Emory.
- Company must maintain liability insurance as described in the Space Use License Agreement.
- Company must comply with all local, state, and federal laws and regulations as well as Emory University policies and procedures regarding environmental health and safety (EHS).
- Company will participate in annual progress review process.
Built for you
Amenities
- 22 dedicated desks in a shared workstations area
- Kaldi’s Café
- Shared breakroom
- Bike storage room
- Commuter shower facilities
- Lactation rooms
- Outdoor plaza with seating
Biolocity Programming
Lab2Launch residents will also be able to leverage the network, and rich business development and technical programming provided by Biolocity - a sister program, that funds and assists promising early stage teams through consultation and project management in their commercialization journey. In addition to procuring a state-of-the-art laboratory, we support your R&D goals by facilitating improved access to:
- Legal office hours
- Educational resources
- Business development and technical programming
- Networking events
Health Sciences Research Building II Innovation Floor
The Innovation Floor, named the Raymond F. Schinazi Family Innovation Floor, is made possible by a generous gift from Raymond F. Schinazi, PhD, Hon DSc, FAASLD. The Innovation Floor includes the lobby, Lab2Launch, a 3-D printing and micro-machining area, extended reality and artificial intelligence technologies and seminar space.
"In my experience, you need to create new companies to take scientific discoveries from the laboratory to the clinic. These highly-focused, entrepreneurial enterprises can move more quickly and more cheaply from discovery to development than larger, more complex pharmaceutical companies. I believe that the modern tools and extensive resources available through the Innovation Floor will accelerate the ability of start-up companies to transform laboratory discoveries into drugs that prevent, treat and, ultimately, cure life-threatening diseases."